A randomised, sham-controlled, double-blind, multicenter clinical trial to evaluate the percutaneous pulsed radiofrequency treatment at the dorsal root ganglion - PRF at the DRG

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•1) Age 18 years or older
•2) Anamnesis and physical investigation suggestive of lumbosacral radicular pain for more than 3 months
•3) Decrease in NRS of 2 or more / 10 on diagnostic block at the DRG

•1) Presence of red flags: possible fracture (major trauma, minor trauma in elderly or osteoporotic), possible tumor or infection (age >50 or <20, history of cancer, constitutional symptoms (fever, chills, weight loss), recent bacterial infection, IV drug abuse, immunosuppression, pain worsening at night or when supine), possible significant neurological deficit (severe or progressive sensory alteration or weakness, bladder or bowel dysfunction, evidence of neurological deficit (in legs or perineum in the case of low back pain)
•2) Aspecific low back pain
•3) Corpus vertebrae problem
•4) Progressive neurological defecits
•5) Major psychiatric disorder (according to psychiatrists opinion)
•6) Anticoagulation cannot be stopped
•7) Active infection
•8) Pain in other parts of the body that is more severe (including facet joint -, SI joint - and discogenic pain)
•9) Allergies to any medication used in the study
•10) Pregnancy
•11) Communication (language) difficulties (according to physicians opinion)

发起方